001     1032442
005     20250203133219.0
024 7 _ |a 10.1186/s42466-024-00350-3
|2 doi
024 7 _ |a 10.34734/FZJ-2024-06248
|2 datacite_doi
024 7 _ |a 39472968
|2 pmid
024 7 _ |a WOS:001344817300001
|2 WOS
037 _ _ |a FZJ-2024-06248
082 _ _ |a 610
100 1 _ |a Goerttler, Tsepo
|0 0000-0002-1868-440X
|b 0
|e Corresponding author
245 _ _ |a Iatrogenic botulism after intragastric botulinum neurotoxin injections – a major outbreak
260 _ _ |a [London]
|c 2024
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1731654717_17956
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Supported by the DFG in the framework of the DFG Clinician Scientist Programme UMEA, FU356/12-2
520 _ _ |a AbstractBackgroundIntragastric botulinum neurotoxin injections (IBNI) are offered off-label in the private medical sector in a few European countries as a safe and effective weight-loss measure. In February and March 2023, an outbreak of iatrogenic botulism occurred in several European countries following IBNI treatment in Turkey. This case series describes the clinical features of severe iatrogenic botulism after IBNI.MethodsWe retrospectively summarize the clinical course and emergency department and intensive care unit interventions in ten cases of severe iatrogenic botulism that occurred after receiving IBNI in this sudden outbreak in Austria and Germany.ResultsSeven out of ten cases initially showed characteristic symptoms of botulism with diplopia, dysphagia, dysarthria, dysarthrophonia, and descending paralysis. All patients were hospitalized, six in an intensive care unit and partially requiring mechanical ventilation. All patients recovered and were discharged without relevant permanent deficits.ConclusionOur study highlights ten clinical cases in this iatrogenic botulism outbreak, representing the largest reported outbreak worldwide. Clinicians should be aware of the risks associated with medical procedures involving botulinum neurotoxins and ensure measures to minimize the risk of iatrogenic botulism.
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Dorner, Martin B.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a van der Linden, Christina
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Kienitz, Ricardo
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Petrik, Stephan
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Blechinger, Stephan
|b 5
700 1 _ |a Spickschen, Jonah
|b 6
700 1 _ |a Betz, Iris R.
|b 7
700 1 _ |a Hinrichs, Carl
|b 8
700 1 _ |a Steindl, David
|b 9
700 1 _ |a Weber, Frederike
|0 P:(DE-Juel1)176463
|b 10
700 1 _ |a Musacchio, Thomas
|b 11
700 1 _ |a Wunderlich, Gilbert
|b 12
700 1 _ |a Rueger, Maria Adele
|b 13
700 1 _ |a Barbe, Michael T.
|0 P:(DE-Juel1)131613
|b 14
700 1 _ |a Dafsari, Haidar
|b 15
700 1 _ |a Demir, Seda
|b 16
700 1 _ |a Lapa, Sriramya
|b 17
700 1 _ |a Zeiner, Pia S.
|b 18
700 1 _ |a Strzelczyk, Adam
|b 19
700 1 _ |a Tinnemann, Peter
|b 20
700 1 _ |a Kleine, Christian
|b 21
700 1 _ |a Totzeck, Andreas
|b 22
700 1 _ |a Klebe, Stephan
|b 23
700 1 _ |a Mikolajewska, Agata
|b 24
700 1 _ |a Dorner, Brigitte G.
|b 25
700 1 _ |a Fertl, Elisabeth
|b 26
700 1 _ |a Grefkes-Hermann, Christian
|b 27
700 1 _ |a Fink, Gereon
|0 P:(DE-Juel1)131720
|b 28
700 1 _ |a Kleinschnitz, Christoph
|0 P:(DE-HGF)0
|b 29
700 1 _ |a Hagenacker, Tim
|0 P:(DE-HGF)0
|b 30
773 _ _ |a 10.1186/s42466-024-00350-3
|g Vol. 6, no. 1, p. 52
|0 PERI:(DE-600)2947493-0
|n 1
|p 52
|t Neurological research and practice
|v 6
|y 2024
|x 2524-3489
856 4 _ |u https://juser.fz-juelich.de/record/1032442/files/PDF.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:1032442
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)176463
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 28
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
914 1 _ |y 2024
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:42:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:42:53Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-04-10T15:42:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-30
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21